1-[(1,3-Oxazol-2-yl)methyl]piperazine dihydrochloride

Catalog No.: 
ACTCET094
CAS No.: 
1955561-52-0
Molecular Formula: 
C8H15Cl2N3O
Molecular Weight: 
240.13
1-[(1,3-Oxazol-2-yl)methyl]piperazine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$440.00InquiryInquiry
100mg95%$650.00InquiryInquiry
250mg95%$923.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(1,3-Oxazol-2-yl)methyl]piperazine dihydrochloride
IUPAC Name2-(piperazin-1-ylmethyl)oxazole dihydrochloride
MDL No.-
Molecular FormulaC8H15Cl2N3O
Molecular Weight240.13
SMILES[H]Cl.[H]Cl.N1(CC2=NC=CO2)CCNCC1
InChI KeySCVHEXCABZPPDE-UHFFFAOYSA-N
Synonym1-[(1,3-oxazol-2-yl)methyl]piperazine dihydrochloride
CAS No.1955561-52-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACTCET094 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACGSKM479 route compound structure diagram
    ACGSKM479185246-17-7In Stock
  4. Then
  5. ACTCET094 route product structure diagram
    ACTCET0941955561-52-0
Inquiry

2. ACTCET094 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACBSRM842 route compound structure diagram
    ACBSRM84265373-52-6In Stock
  4. Then
  5. ACTCET094 route product structure diagram
    ACTCET0941955561-52-0
Inquiry

3. ACTCET094 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTCET094 route product structure diagram
    ACTCET0941955561-52-0
Inquiry

Comments (0)